Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells - PubMed (original) (raw)

Review

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells

Alison H Banham. Trends Immunol. 2006 Dec.

Abstract

FOXP3+ regulatory T (Treg) cells have crucial roles in maintaining self-tolerance and modulating adaptive immune responses. Functional studies of Treg cells have been hampered by a lack of suitable cell-surface markers that specifically enable their purification without contamination by non-regulatory CD25+ effector T cells. Two recent studies have demonstrated that downregulation of the interleukin-7 receptor (CD127) distinguishes Treg cells from activated T cells, facilitating both Treg-cell purification and their functional characterization in human diseases. CD127 uniquely enables the purification of FOXP3+ Treg cells and, potentially, also "adaptive" regulatory T-cell subsets from the CD4+CD25- T-cell population.

PubMed Disclaimer

Similar articles

• No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
  Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M. Brusko T, et al. Diabetes. 2007 Mar;56(3):604-12. doi: 10.2337/db06-1248. Diabetes. 2007. PMID: 17327427
• Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
  Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N. Cao Q, et al. Cell Res. 2007 Jul;17(7):627-37. doi: 10.1038/cr.2007.46. Cell Res. 2007. PMID: 17563757
• The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.
  Zhang L, Zhao Y. Zhang L, et al. J Cell Physiol. 2007 Jun;211(3):590-7. doi: 10.1002/jcp.21001. J Cell Physiol. 2007. PMID: 17311282 Review.
• The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
  Qu Y, Zhang B, Zhao L, Liu G, Ma H, Rao E, Zeng C, Zhao Y. Qu Y, et al. Transpl Immunol. 2007 Apr;17(3):153-61. doi: 10.1016/j.trim.2007.01.002. Epub 2007 Jan 24. Transpl Immunol. 2007. PMID: 17331841
• Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.
  Horwitz DA, Zheng SG, Gray JD. Horwitz DA, et al. Trends Immunol. 2008 Sep;29(9):429-35. doi: 10.1016/j.it.2008.06.005. Epub 2008 Aug 3. Trends Immunol. 2008. PMID: 18676178 Review.

Cited by

• Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.
  Horta A, Nobrega C, Amorim-Machado P, Coutinho-Teixeira V, Barreira-Silva P, Boavida S, Costa P, Sarmento-Castro R, Castro AG, Correia-Neves M. Horta A, et al. PLoS One. 2013;8(2):e57336. doi: 10.1371/journal.pone.0057336. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437372 Free PMC article.
• The discovery of novel experimental therapies for inflammatory arthritis.
  Malemud CJ. Malemud CJ. Mediators Inflamm. 2009;2009:698769. doi: 10.1155/2009/698769. Epub 2010 Mar 18. Mediators Inflamm. 2009. PMID: 20339519 Free PMC article. Review.
• Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors.
  Jacobs JF, Idema AJ, Bol KF, Nierkens S, Grauer OM, Wesseling P, Grotenhuis JA, Hoogerbrugge PM, de Vries IJ, Adema GJ. Jacobs JF, et al. Neuro Oncol. 2009 Aug;11(4):394-402. doi: 10.1215/15228517-2008-104. Epub 2008 Nov 21. Neuro Oncol. 2009. PMID: 19028999 Free PMC article.
• Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.
  Tan YV, Abad C, Wang Y, Lopez R, Waschek JA. Tan YV, et al. PLoS One. 2013 Apr 16;8(4):e61200. doi: 10.1371/journal.pone.0061200. Print 2013. PLoS One. 2013. PMID: 23613811 Free PMC article.
• Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.
  Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, Donkova-Petrini V, Levy Y, Girard PM, Burgard M, Viard JP, Rouzioux C, Costagliola D; ANRS 116 SALTO study group. Weiss L, et al. PLoS One. 2010 Jul 21;5(7):e11659. doi: 10.1371/journal.pone.0011659. PLoS One. 2010. PMID: 20657770 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program